Intercontinental Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

Intercontinental Wealth Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$224K	Buy	+9,000	New	+$232K	0.05%	294

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Intercontinental Wealth Advisors's TGTX Position: Q2 2023 in Review

Intercontinental Wealth Advisors opened a new position in TG Therapeutics (TGTX) in Q2 2023: 9,000 shares worth $224K. The stake represents 0.05% of the portfolio and ranks #294 among its holdings.

244 funds tracked by Wall St. Rank hold TGTX as of Q2 2023.

Intercontinental Wealth Advisors held 9,000 shares of TG Therapeutics worth $224K as of Q2 2023.
TG Therapeutics was a new Intercontinental Wealth Advisors position in Q2 2023.
TG Therapeutics made up 0.05% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #294 holding.
244 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.